Cargando…
Dopamine and α-synuclein dysfunction in Smad3 null mice
BACKGROUND: Parkinson's disease (PD) is characterized by dopaminergic neurodegeneration in the substantia nigra (SN). Transforming growth factor-β1 (TGF-β1) levels increase in patients with PD, although the effects of this increment remain unclear. We have examined the mesostriatal system in ad...
Autores principales: | Tapia-González, Silvia, Giráldez-Pérez, Rosa M, Cuartero, M Isabel, Casarejos, M José, Mena, M Ángeles, Wang, Xiao-Fan, Sánchez-Capelo, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219599/ https://www.ncbi.nlm.nih.gov/pubmed/21995845 http://dx.doi.org/10.1186/1750-1326-6-72 |
Ejemplares similares
-
Smad3 is required for the survival of proliferative intermediate progenitor cells in the dentate gyrus of adult mice
por: Tapia-González, Silvia, et al.
Publicado: (2013) -
Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014) -
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit
por: Tozzi, Alessandro, et al.
Publicado: (2021) -
A Molotov cocktail: dopamine and α-synuclein
por: Tuma, Rabiya
Publicado: (2002) -
Dopamine-Mediated Oxidation of Methionine 127 in α-Synuclein Causes Cytotoxicity and Oligomerization of α-Synuclein
por: Nakaso, Kazuhiro, et al.
Publicado: (2013)